問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
黃駿逸
下載
2022-01-01 - 2025-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting4Sites
Terminated2Sites
2023-01-05 - 2026-12-13
Participate Sites5Sites
Recruiting5Sites
2019-12-01 - 2022-12-31
Advanced Biliary Tract Cancer
OPDIVO
Participate Sites7Sites
Recruiting7Sites
2022-09-01 - 2025-03-07
Participate Sites4Sites
2019-11-30 - 2026-09-30
xxxxxx
Participate Sites9Sites
Recruiting9Sites
2022-02-16 - 2026-12-31
Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma
ADI-PEG 20
2022-06-01 - 2026-12-31
Recruiting6Sites
2021-11-01 - 2025-12-31
2020-09-01 - 2022-08-31
2019-08-01 - 2021-11-03
Chronic Hepatitis B
HLX10
Participate Sites3Sites
Recruiting3Sites
全部
